- Published at
- by marketscreener.com
mixed
mixed
Autolus Therapeutics Announces Changes to its Board of Directors
LONDON, April 01, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike...